rs879255704
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_001330260.2(SCN8A):c.3979A>G(p.Ile1327Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Consequence
SCN8A
NM_001330260.2 missense
NM_001330260.2 missense
Scores
13
4
2
Clinical Significance
Conservation
PhyloP100: 9.32
Genes affected
SCN8A (HGNC:10596): (sodium voltage-gated channel alpha subunit 8) This gene encodes a member of the sodium channel alpha subunit gene family. The encoded protein forms the ion pore region of the voltage-gated sodium channel. This protein is essential for the rapid membrane depolarization that occurs during the formation of the action potential in excitable neurons. Mutations in this gene are associated with cognitive disability, pancerebellar atrophy and ataxia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 13 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SCN8A. . Gene score misZ 0.78755 (greater than the threshold 3.09). Trascript score misZ 10.436 (greater than threshold 3.09). GenCC has associacion of gene with myoclonus, familial, 2, infantile convulsions and choreoathetosis, cognitive impairment with or without cerebellar ataxia, undetermined early-onset epileptic encephalopathy, complex neurodevelopmental disorder, developmental and epileptic encephalopathy, 13, benign familial infantile epilepsy, seizures, benign familial infantile, 5.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.939
PP5
Variant 12-51786578-A-G is Pathogenic according to our data. Variant chr12-51786578-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 253288.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN8A | NM_001330260.2 | c.3979A>G | p.Ile1327Val | missense_variant | 22/27 | ENST00000627620.5 | NP_001317189.1 | |
SCN8A | NM_014191.4 | c.3979A>G | p.Ile1327Val | missense_variant | 22/27 | ENST00000354534.11 | NP_055006.1 | |
SCN8A | NM_001177984.3 | c.3856A>G | p.Ile1286Val | missense_variant | 21/26 | NP_001171455.1 | ||
SCN8A | NM_001369788.1 | c.3856A>G | p.Ile1286Val | missense_variant | 21/26 | NP_001356717.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN8A | ENST00000354534.11 | c.3979A>G | p.Ile1327Val | missense_variant | 22/27 | 1 | NM_014191.4 | ENSP00000346534.4 | ||
SCN8A | ENST00000627620.5 | c.3979A>G | p.Ile1327Val | missense_variant | 22/27 | 5 | NM_001330260.2 | ENSP00000487583.2 | ||
SCN8A | ENST00000599343.5 | c.4012A>G | p.Ile1338Val | missense_variant | 21/26 | 5 | ENSP00000476447.3 | |||
SCN8A | ENST00000355133.7 | c.3856A>G | p.Ile1286Val | missense_variant | 20/25 | 1 | ENSP00000347255.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 14, 2024 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this missense variant does not alter protein structure/function; This substitution is predicted to be within the transmembrane segment S5 of the third homologous domain; This variant is associated with the following publications: (PMID: 24352161, 32090326, 35365919, 36007526, 37432431, 35982159, 27375106, 26993267, 25799905) - |
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 01, 2020 | This variant occurs de novo in an individual tested at Athena Diagnostics and in published literature (PMID: 26993267, 24352161, 25799905). This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). Assessment of experimental evidence suggests that this variant alters the voltage-gated sodium channel (PMID: 27375106).This observation is not an independent occurrence and has been identified in the same individual by RCIGM, the other laboratory participating in the GEMINI study. - |
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 05, 2022 | Experimental studies have shown that this missense change affects SCN8A function (PMID: 27375106). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SCN8A protein function. ClinVar contains an entry for this variant (Variation ID: 253288). This missense change has been observed in individual(s) with epileptic encephalopathy (PMID: 24352161, 25799905, 26993267). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1327 of the SCN8A protein (p.Ile1327Val). For these reasons, this variant has been classified as Pathogenic. - |
SCN8A-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego | - | This variant has been previously reported as a de novo heterozygous change and as a heterozygous change of unknown inheritance in several individuals with SCN8A-related early-infantile epileptic encephalopathy (PMID: 24352161, 25799905, 31010614, 30078772, 26993267, 33915942). In-vitro functional studies showed that the p.Ile1327Val variant leads to an impaired channel inactivation suggesting a gain-of-function effect (PMID: 24352161, 27375106). The p.Ile1327Val variant is absent from the gnomAD population database and thus is presumed to be rare. The c.3979A>G (p.Ile1327Val) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Based on the available evidence, the c.3979A>G (p.Ile1327Val) variant is classified as Pathogenic. - |
Complex neurodevelopmental disorder Other:1
not provided, no classification provided | literature only | Channelopathy-Associated Epilepsy Research Center | - | - - |
Developmental and epileptic encephalopathy, 13 Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Uncertain
D;.;.;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;.;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;.;.;.;M
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N;.;.
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;.;.
Sift4G
Uncertain
D;D;D;D;D
Polyphen
D;.;.;.;.
Vest4
MutPred
Gain of catalytic residue at I1327 (P = 0.0235);.;.;.;Gain of catalytic residue at I1327 (P = 0.0235);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at